Medically reviewed by Dr. Sarah Collins, MPharm, AHPRA Registered Pharmacist — Updated April 2026
What Is Lovegra and How Is It Different From Men's Viagra?
The key difference: The active ingredient — sildenafil citrate — is chemically identical in both Lovegra and men's Viagra. The difference is in the intended user and marketing, not the pharmacology. Both work via the same PDE5 inhibition mechanism. The clinical question of whether sildenafil produces meaningful sexual benefit for women has been the subject of extensive research — with results that are nuanced and depend heavily on the underlying cause of sexual dysfunction.
Female Sexual Dysfunction in Australia — Understanding the Condition
Female sexual dysfunction (FSD) is an umbrella term encompassing several distinct disorders that cause persistent distress related to sexual function. The most common categories relevant to Lovegra's mechanism of action are:
- Female Sexual Arousal Disorder (FSAD): Persistent or recurrent inability to attain or maintain adequate genital lubrication-swelling response of sexual excitement until completion of sexual activity, causing personal distress. FSAD is the female analogue of erectile dysfunction — both involve insufficient genital blood flow in response to sexual stimulation
- Female Sexual Interest/Arousal Disorder (FSIAD — DSM-5): The 2013 DSM-5 combined hypoactive sexual desire disorder (HSDD) and FSAD into FSIAD — reflecting the frequent co-occurrence of desire and arousal difficulties in women
- Genital Arousal Disorder: Absent or impaired genital sexual arousal including absence of vulvovaginal lubrication, clitoral engorgement, and other somatic responses, despite subjective arousal
Australian prevalence: Studies consistently find that 40–45% of Australian women report sexual concerns at some point in their lives. The Australian Longitudinal Study on Women's Health (ALSWH) documents significant rates of sexual dysfunction across age groups — with menopause, chronic health conditions, relationship factors, medications (particularly SSRIs, SNRIs, hormonal contraceptives) and psychological factors all contributing. Despite high prevalence, Australian women are significantly under-served in terms of pharmacological treatment options compared to men — reflecting a historical gap in female sexual health research and treatment development.
How Lovegra Works — The PDE5 Mechanism in Women
Sildenafil's mechanism of action in women mirrors its mechanism in men, acting on the same biochemical pathway but in different anatomical structures:
During sexual stimulation, nitric oxide (NO) is released in genital tissues — including the clitoris, vaginal walls, and labia. NO activates guanylate cyclase, which produces cyclic GMP (cGMP). cGMP causes smooth muscle relaxation in genital blood vessels, increasing blood flow to clitoral and vaginal tissue. This produces clitoral engorgement, transudate-mediated vaginal lubrication, and heightened tactile sensitivity — the physiological components of female genital arousal.
PDE5 — the enzyme that breaks down cGMP — is present in significant concentrations in female genital tissue, including clitoral smooth muscle and vaginal epithelium. Sildenafil inhibits PDE5, preserving elevated cGMP levels and sustaining the genital arousal response during sexual stimulation.
Why Lovegra requires sexual stimulation: Like men's Viagra, Lovegra does not produce arousal or desire spontaneously. It enhances and facilitates the physiological arousal response to sexual stimulation — it does not replace desire, emotional connection, or psychological arousal. This is critical: Lovegra addresses the genital (peripheral) component of sexual arousal, not the central (brain) component of sexual desire.
Clinical Evidence — What Research Shows for Women
The evidence for sildenafil in women is more nuanced than for men, and depends critically on the underlying cause of dysfunction:
Strongest evidence — FSAD associated with physiological causes:
- SSRI/SNRI-induced sexual dysfunction: Multiple randomised controlled trials have demonstrated that sildenafil significantly improves genital arousal, lubrication, and orgasm in women experiencing sexual dysfunction as a side effect of antidepressants (SSRIs such as fluoxetine, sertraline; SNRIs such as venlafaxine). Nurnberg et al. (JAMA, 2008) — a landmark RCT of 98 women with SSRI-induced sexual dysfunction — demonstrated significant improvement in sexual functioning scores with sildenafil vs placebo. This is the indication where evidence for sildenafil in women is most compelling
- Post-menopausal FSAD: Some RCT evidence supports sildenafil improving genital blood flow and subjective arousal in post-menopausal women with FSAD, particularly those with primarily physiological (rather than psychological or relational) contributors to dysfunction
- Diabetes-related female sexual dysfunction: Sildenafil has shown benefit in women with diabetes, where vascular and neurological changes impair genital blood flow in a manner analogous to male diabetic erectile dysfunction
- Spinal cord injury: Clinical data supports sildenafil improving genital arousal in women with spinal cord injuries, where reflex genital responses are disrupted
Weaker or inconsistent evidence:
- Psychogenic FSAD without physiological contributors — sildenafil's peripheral vascular mechanism is less relevant when the dysfunction is primarily central/psychological. Evidence is inconsistent for women without identifiable physiological causes of dysfunction
- Hypoactive sexual desire disorder (low libido) as the primary complaint — sildenafil does not affect sexual desire or libido. For low desire, flibanserin (Addyi) has US FDA approval but is not TGA-approved in Australia
The Basson model context: The circular sexual response model developed by Canadian sex therapist Rosemary Basson highlights that for many women, sexual desire often follows (rather than precedes) physical arousal — meaning that improving genital arousal response with sildenafil can create a positive feedback loop that also improves subjective desire and satisfaction in women with FSAD.
Lovegra vs Other Female Sexual Dysfunction Treatments in Australia
| Lovegra (Sildenafil 100mg) | Flibanserin (Addyi) | Bremelanotide (Vyleesi) | Ospemifene (Osphena) | |
|---|---|---|---|---|
| Mechanism | PDE5 inhibitor — peripheral genital blood flow | 5-HT1A agonist / 5-HT2A antagonist — central desire pathway | Melanocortin receptor agonist — central arousal/desire | Selective oestrogen receptor modulator — vaginal tissue |
| Primary indication | FSAD — genital arousal disorder | HSDD — hypoactive sexual desire (pre-menopausal) | HSDD (pre-menopausal) | Dyspareunia from vaginal atrophy |
| Route | Oral — on-demand | Oral — daily (bedtime) | Subcutaneous injection — on-demand | Oral — daily |
| TGA approval Australia | Not TGA-registered for women | Not TGA-approved | Not TGA-approved | Not widely available in Australia |
| Best suited for | SSRI-induced dysfunction, physiological FSAD, post-menopausal FSAD | Low libido/desire (premenopausal) | Low desire + arousal (premenopausal) | Post-menopausal vaginal dryness and painful sex |
| Onset | 30–60 minutes | 4–8 weeks of daily use | 45 minutes (injection) | Weeks of daily use |
| Does NOT treat | Low desire, psychological FSD | Genital arousal disorder | Genital arousal disorder | Arousal or desire |
| Evidence strength in women | Moderate-strong for physiological FSAD | Modest — FDA-approved but effect size small | Moderate | Good for indication |
Dosage and Usage Instructions
Standard dose: One 100mg tablet taken 30 to 60 minutes before anticipated sexual activity. This is the dose used in clinical trials of sildenafil in women. Some women may find a lower dose (50mg — half tablet) adequate with fewer side effects.
With food or without? Lovegra is best taken on an empty stomach or with a light meal. A high-fat meal delays absorption significantly — potentially extending the time before effect from 60 minutes to 90–120 minutes. A light meal has minimal impact. Avoid grapefruit and grapefruit juice on the day of use — grapefruit inhibits CYP3A4 and can unpredictably increase sildenafil blood levels.
Alcohol: One to two standard drinks are generally tolerated by most healthy women. Larger amounts of alcohol should be avoided — alcohol impairs sexual response directly and may compound sildenafil's blood pressure-lowering effects. Avoid heavy drinking on days when taking Lovegra.
Frequency: No more than one dose in 24 hours. Lovegra is an on-demand medication — not taken daily.
Requires sexual stimulation: Lovegra will not produce arousal, desire or lubrication without sexual stimulation. It enhances the physiological response to stimulation — it does not replace it.
Missed dose: As an on-demand medication, a missed dose concept does not apply — take when needed before sexual activity.
Safety — Absolute Contraindications
Never combine Lovegra with:
- Nitrate medications (glyceryl trinitrate/GTN spray, isosorbide dinitrate, isosorbide mononitrate) — used for angina. The combination causes a potentially fatal drop in blood pressure. Absolute contraindication. Call 000 if accidental combination occurs
- Recreational drugs known as "poppers" (amyl nitrite, butyl nitrite) — same mechanism, same life-threatening blood pressure drop. Absolute contraindication
- Riociguat (Adempas) — used for pulmonary arterial hypertension. Absolute contraindication
- Other PDE5 inhibitors (tadalafil, vardenafil, avanafil) — do not combine
- Strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) — can increase sildenafil blood levels many-fold. Reduce dose to 25mg (quarter tablet) if any of these medications are essential
Use with caution in: women taking antihypertensive medications (additive blood pressure lowering), alpha-blockers (tamsulosin — blood pressure drop risk), women with cardiovascular disease, severe hepatic impairment, retinitis pigmentosa.
Side Effects
Very common (affecting more than 1 in 10 users):
- Headache — most common; typically mild and transient
- Facial flushing and warmth
- Nasal congestion
- Indigestion
Common (affecting up to 1 in 10 users):
- Dizziness — rise slowly from lying or sitting to reduce orthostatic hypotension risk
- Visual disturbances — blue tinge, increased light sensitivity, blurred vision (PDE6 cross-reactivity in retinal photoreceptors). Transient and dose-dependent. Do not drive if visual disturbances occur
- Nausea
Rare but serious — seek immediate medical attention:
- Sudden vision loss — non-arteritic anterior ischaemic optic neuropathy (NAION). Stop medication immediately and call 000
- Sudden hearing loss or tinnitus — stop and seek emergency care
- Severe hypotension — chest pain, fainting. Call 000
- Severe allergic reactions — swelling of face, lips, tongue, throat; breathing difficulty. Call 000
TGA Status in Australia and Regulatory Context
In Australia, sildenafil is a Schedule 4 (prescription only) medicine regulated by the Therapeutic Goods Administration (TGA). Lovegra (sildenafil marketed for women) is not TGA-registered as a specific product — it falls into the category of unregistered therapeutic goods. The TGA permits Australian residents to import up to a 3-month personal supply of unregistered therapeutic goods for personal use under the TGA's Personal Importation Scheme (Section 19(1) Therapeutic Goods Act 1989), provided the goods are for personal therapeutic use and are not for supply to others.
Our recommendation: We strongly recommend consulting an Australian healthcare provider — GP, gynaecologist, or sexual health clinician — before starting Lovegra, particularly if you have cardiovascular conditions, take multiple medications, or if this is your first time using a PDE5 inhibitor. Australian telehealth platforms including Monash IVF, Vera Women's Wellness, and Jean Hailes for Women's Health provide specialist sexual health consultations. Your GP can assess whether sildenafil is appropriate for your specific situation.
Delivery to All Australian States and Territories
redstonerx-au.com ships Lovegra discreetly to all Australian states and territories. Standard delivery: 4–9 business days.
New South Wales (Sydney, Newcastle, Wollongong, Central Coast) — Victoria (Melbourne, Geelong, Ballarat, Bendigo) — Queensland (Brisbane, Gold Coast, Sunshine Coast, Cairns, Townsville) — Western Australia (Perth, Fremantle, Bunbury) — South Australia (Adelaide, Mount Gambier) — Tasmania (Hobart, Launceston) — Australian Capital Territory (Canberra) — Northern Territory (Darwin, Alice Springs).
All orders are dispatched in plain, unmarked packaging with no reference to the contents or sender. A tracking number is provided with every order.
Frequently Asked Questions — Lovegra in Australia
Does Lovegra actually work for women? The clinical evidence is most compelling for women with physiological causes of female sexual arousal disorder — particularly SSRI/SNRI antidepressant-induced sexual dysfunction, post-menopausal FSAD, and diabetes-related sexual dysfunction. The landmark Nurnberg et al. JAMA 2008 trial demonstrated significant improvement in sexual function scores with sildenafil vs placebo in women with antidepressant-induced sexual dysfunction. For women with primarily psychological or relational causes of low desire (hypoactive sexual desire disorder), sildenafil's peripheral vascular mechanism is less relevant — addressing psychological contributors with a sex therapist or psychologist is more appropriate in those cases.
Is Lovegra the same as Viagra for men? Yes — the active ingredient (sildenafil citrate 100mg) and the pharmacological mechanism (PDE5 inhibition) are identical. The difference is in marketing and the intended user population. The clinical effects differ because male and female genital anatomy differ — in men sildenafil facilitates penile erection; in women it enhances clitoral engorgement, vaginal lubrication, and genital tactile sensitivity.
Will Lovegra increase my sexual desire (libido)? No — Lovegra addresses the physiological (genital) component of sexual arousal, not the central (desire/libido) component. If low libido is your primary concern rather than physical arousal difficulties, sildenafil is unlikely to be helpful. Desire and arousal are physiologically distinct. Speak with a sexual health clinician about options for low desire.
Can I take Lovegra if I am on antidepressants? This is precisely one of the situations where the evidence for sildenafil in women is strongest — SSRI/SNRI-induced sexual dysfunction is a common and distressing side effect of antidepressants. However, check with your GP or psychiatrist first, as interactions with specific antidepressants and your overall cardiovascular health need to be assessed. There are no major pharmacokinetic interactions between most SSRIs/SNRIs and sildenafil, but clinical oversight is important.
Is it legal to buy Lovegra online in Australia? The TGA's Personal Importation Scheme permits Australian residents to import up to a 3-month personal supply of therapeutic goods not registered in Australia for personal therapeutic use. This is the regulatory framework under which personal imports of Lovegra occur. The goods must be for your own personal use, not for supply to others. We recommend consulting an Australian GP before use.
How long does delivery to Australia take? Standard delivery to all Australian states and territories takes 4 to 9 business days. All orders arrive in plain, unmarked packaging with no reference to the contents or sender. Every order includes a tracking number.
All information on this page is for general informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new medication.
